Literature DB >> 22158312

3. Cancers attributable to consumption of alcohol in the UK in 2010.

D M Parkin1.   

Abstract

Entities:  

Mesh:

Year:  2011        PMID: 22158312      PMCID: PMC3252062          DOI: 10.1038/bjc.2011.476

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


× No keyword cloud information.
In 1988, the International Agency for Research on Cancer (IARC) Monograph on the carcinogenic risk to humans of alcohol drinking concluded that the occurrence of malignant tumours of the oral cavity, pharynx, larynx, oesophagus and liver was causally related to the consumption of alcoholic beverages. In an updated review (Baan ; Secretan ), they noted the consistent finding of an increased risk of breast cancer with increasing alcohol intake, and that an association between alcohol consumption and colorectal cancer had been reported by more than 50 prospective and case–control studies, with no difference in the risk for colon and rectal cancers (Baan ). The World Cancer Research Fund report (WCRF, 2007) considered that the evidence for an association of alcohol intake with these sites was convincing and, for liver cancer, probable.

Methods

Quantitative risk of alcohol

Table 1 shows the increase in risk associated with consumption of 1 g per day of alcohol. The estimates in these studies had been adjusted for major confounders, notably smoking.
Table 1

Increase in risk of cancer associated with 1 gram of alcohol per day

Cancer type Studies Increase in risk per gram alcohol per day
Oral cavity and pharynx Corrao et al (2004) 0.0185
Larynx Corrao et al (2004) 0.0136
Oesophagus Corrao et al (2004) 0.0129
Colorectal cancer Cho et al (2004) 0.0080
  Moskal et al (2007)  
  Ferrari et al (2007)  
  WCRF (2007)  
BreastCollaborative Group (Hamajima et al, 2002)0.0071
Liver Corrao et al (2004) 0.0059
With respect to breast cancer, the estimate was derived from a meta-analysis of 53 studies, conducted by the Collaborative Group on Hormonal Factors in Breast Cancer (Hamajima ), which found that the risk was increased by 7.1% for every 10 g of daily alcoholintake. The values observed in subsequent studies are not substantially different. A pooled analysis of six cohort studies with data on alcohol and dietary factors found that the risk of breast cancer increased monotonically with increasing intake of alcohol; the multivariate relative risk (RR) for a 10-g per day increase in alcohol was 1.09 (95% CI=1.04–1.13; Smith-Warner ). The EPIC study (Tjønneland ) found that the risk was 1.03 (95% CI=1.01–1.05) per 10-g per day recent alcohol intake, whereas in the Million Women Study the increase in risk associated with 10 g per day intake was 12% (Allen ). With respect to cancers of the colorectum, a pooled analysis of eight cohort studies reported a borderline statistically significant 16% risk increase for people drinking 30–45 g per day of alcohol and a significant 41% risk increase for people drinking ⩾45 g per day (Cho ). A more recent meta-analysis of cohort studies found a 15% increase in the risk of colon or rectal cancer for an increase of 100 g alcohol intake per week (Moskal ), with no difference between men and women. In the EPIC study (Ferrari ), the effect was a bit weaker, with alcohol intake at study baseline increasing colorectal cancer risk by 9% per 15 g per day, a risk greater for rectal cancer than for cancer of the distal colon, which in turn was greater than the risk for cancer of the proximal colon. In the WCRF (2007) report, a meta-analysis of eight studies of colon cancer yielded a combined RR of 1.09 (1.03–1.14) per 10 g intake per day, and a meta-analysis of nine studies of rectal cancer yielded an RR of 1.06 (1.01–1.12) per 10 g intake per day. The means in the meta-analyses of Cho , Moskal , the EPIC study (Ferrari ) and WCRF (2007) are 0.75% per gram alcohol per day for colon cancer and 0.85% per gram per day for rectal cancer. As these estimates are similar, the global figure of 0.8% per gram (increase of 0.008 per gram per day) was used for colorectal cancer as a whole (Table 1). For the remaining cancers, the meta-analysis of Corrao was used to estimate the RRs. They present RRs associated with a mean intake of 0, 25, 50 and 100 g of alcohol per day. The RR per gram of alcohol intake was estimated by assuming a log–linear relationship between exposure and risk, so that: where x is the exposure level (in grams per day).

Prevalence of exposure to alcohol

The latent period or interval between ‘exposure’ to alcohol and the appropriate increase in risk of these cancers is not known. We chose to assume that this would be, on average, 10 years, and thus examine the effects on cancers occurring in 2010 from non-optimal levels of alcohol consumption in the year 2000. There are two main ways of measuring the amount of alcohol consumed: asking people how much alcohol they drink or counting how much alcohol is sold. As the estimates of the effect of past alcohol drinking on cancer risk are based on epidemiological studies in which alcohol intake is estimated from questionnaire data, it is most appropriate to base the exposure prevalence on data from a similar source. We have used data from the National Diet and Nutrition Survey, a survey of the diet and nutrition of a representative sample of adults in the age group of 19–64 years living in private households in Great Britain, carried out between July 2000 and June 2001 (Henderson ). For the age group >65 years, we used data on the proportion of non-drinkers, and average alcohol consumption from the General Household Survey (for England) (Goddard, 2006). From these tables, an estimate was prepared of the proportions of individuals (by age group and sex) consuming different quantities of alcohol in terms of grams per day, assuming that 1 unit of alcoholic beverages contains 8 g of pure alcohol (Table 2).
Table 2

Estimated percentage of the population at 12 levels of alcohol consumption

   % of population consuming the specified grams per day alcohol in Great Britain during 2000–2001
Alcohol consumption
Men by age (years)
Women by age (years)
Level Grams per day 19–24 25–34 35–49 50–64 65+ All 19+ 19–24 25–34 35–49 50–64 65+ All 19+
 10201816232620293131334935
 20.5211242023533
 31.5341453865545
 43.5581177811101015911
 57.516910811101616189813
 612.5148614101071211979
 717.541497897107767
 825111116971110791179
 9355711567553344
1045755856402322
1155845365200010
127051191058111000
Mean grams per day 20.422.223.121.112.623.611.49.19.28.67.711.6

Data for 19–64-year-olds from Henderson (2003); data for >65-year-olds from Goddard (2006).

The same data are shown in Figure 1, as the cumulative percentages of men and women of different ages with different levels of alcohol intake in 2000, as grams per day of alcohol.
Figure 1

Cumulative percentage of population with different alcohol intakes.

Estimation of population attributable fractions (PAFs)

For the six cancer types, PAFs were calculated for each sex–age group according to the usual formula: where p is the proportion of the population in consumption level x (x=1–12) and ERR the excess relative risk (RR−1) in consumption level x (x=1–12). The ERR of alcohol consumption for each level x of alcohol consumption given in Table 2 was calculated as follows: where Rg is the increase in risk per gram of alcohol intake (Table 1) and G the intake of alcohol (grams per day) in consumption category x (Table 2).

Results

Table 3 shows for each sex and age group the numbers of cases of the six alcohol-related cancers in the UK in 2010, the PAFs due to alcohol consumption 10 years earlier (2000–2001) and the corresponding number of excess cases (calculated as (observed × PAF)).
Table 3

Cancer cases diagnosed in 2010 attributable to alcohol consumption in 2000–2001

   Cases attributable to alcohol consumption for each cancer
Age (years)
Oral cavity and pharynx
Oesophagus
Colon–rectum
Liver
Larynx
Breast
At exposure At outcome (+10 years) PAF Obs. Excess attrib. cases PAF Obs. Excess attrib. cases PAF Obs. Excess attrib. cases PAF Obs. Excess attrib. cases PAF Obs. Excess attrib. cases PAF Obs. Excess attrib. cases
Men
 15–2425–340.365519.60.25112.80.1613320.80.12192.10.2620.5   
 25–3435–440.3924496.10.288624.00.1739769.20.13435.50.293510.3   
 35–4945–590.401591631.80.28970274.90.182921521.10.1335146.40.30407121.3   
 50–6460–740.381888709.10.262535668.20.1694811548.00.121011121.40.28914253.9   
 ⩾65⩾750.32768249.10.222108473.70.1491621262.70.1082883.70.24444105.3   
Total  45711705.9 57131443.5 22 1273421.8 2270259.1 1803491.3   
%   37.3  25.3  15.5  11.4  27.3   
                    
Women
 15–2425–340.235011.40.1640.60.1013613.00.0712.110.90.1720.30.08715.160.7
 25–3435–440.1813123.20.12273.30.0740229.90.0529.481.60.13121.50.073857254.0
 35–4945–590.18622113.50.1230337.90.082292174.80.06142.88.00.139913.10.0714 628987.4
 50–6460–740.17855146.30.12922108.50.076116440.70.0545323.90.1216820.90.0617 1941096.9
 ⩾65⩾750.16666105.20.111560166.80.068810568.80.05642.430.20.1110111.40.0611 952681.3
Total  2359399.7 2819317.2 17 7871227.3 129864.6 38647.3 48 3853080.3
%   16.9  11.3  6.9  5.0  12.2  6.4
                    
Persons
 15–2425–34 10531.1 153.4 26933.8 313.0 40.9 71560.7
 25–3435–44 375119.3 11327.3 79999.1 727.1 4711.8 3857254.0
 35–4945–59 2213745.4 1273312.8 5213695.9 49454.3 506134.4 14 628987.4
 50–6460–74 2743855.5 3457776.7 15 5971988.8 1464145.4 1082274.8 17 1941096.9
 ⩾65⩾75 1434354.3 3668640.5 17 9721831.5 1470113.9 545116.7 11 952681.3
Total  69302105.6 85321761 39 9144649 3568324 2189539 48 3853080
%   30.4  20.6  11.6  9.1  24.6  6.4

Abbreviations: attrib.=attributable; Obs.=observed cases; PAF=population-attributable fraction.

Because of the high risk of upper aero-digestive tract cancer associated with alcohol drinking, cancers of the mouth and pharynx, as well as larynx, had the highest percentages of alcohol-attributable cases (30.4% of cancers of the oral cavity and pharynx, 24.6% of laryngeal cancers). Although the fractions of colorectal (11.6%) and breast (6.4%) cancers were much lower, the actual numbers of alcohol-attributable cases were much greater – together, they account for about 7700 alcohol-attributable cases in 2010 (or 62% of all alcohol-related cancers). Table 4 sums the excess numbers of cases at the six sites, caused by alcohol consumption, and expresses these numbers as a fraction of the total burden of (incident) cancer. The estimates are 4.6% cancers in men and 3.3% in women due to alcohol consumption, or 4.0% cancers overall.
Table 4

Estimated total numbers of cancers in the UK in 2010, PAFs due to alcohol consumption 10 years earlier (2000–2001), and the corresponding number and percentage of excess cases, by age group and sex

Age (years)
All cancersa
Exposure Outcome (+10 years) Observed cases Excess attributable cases PAF (%)
Men
 15–2425–342109462.2
 25–3435–4441242055.0
 35–4945–5922 38815967.1
 50–6460–7468 04333014.9
 ⩾6575+60 14921753.6
Total 158 66773224.6
     
Women
 15–2425–343284.1872.6
 25–3435–448619.23133.6
 35–4945–5931 63113354.2
 50–6460–7454 96618373.3
 ⩾6575+55 43715642.8
Total 155 58451363.3
     
Persons
 15–2425–3453931332.5
 25–3435–4412 7435194.1
 35–4945–5954 01929305.4
 50–6460–74123 00951384.2
 ⩾6575+115 58637383.2
Total 314 25112 4584.0

Abbreviations: PAF=population-attributable fraction.

Excluding non-melanoma skin cancer.

Discussion

The estimates of the RR of alcohol consumption for various cancers are an ‘average’ taken from widely cited meta-analyses; more extreme values can be found in specific studies. Table 5 compares the excess RRs of 1 g of alcohol consumption per day as used in this study with those from the Million Women Study (Allen ) and the EPIC study (Ferrari ; Tjonneland ), as well as with those derived from various meta-analyses by WCRF (2007). The values for cohort studies are shown for cancers of the breast, colon, rectum and liver. For upper aero-digestive and oesophageal cancers, meta-analyses were based on case–control studies only.
Table 5

Estimates of excess relative risk associated with 1 gram alcohol intake per day

For the most part, the risks associated with consumption of alcohol used in the present study are similar to those in the three comparative studies listed in Table 5. The ERRs reported in the Million Women Study (Allen ) are rather higher than those in Table 1 for cancers of the oesophagus, liver and larynx, although the values used in the current analysis (Table 1) lie within the relevant 95% confidence intervals; for colon cancer, however, the value is considerably lower. With respect to cancer of the oesophagus, some of the differences may relate to the differing proportions of squamous cell and adenocarcinomas in the series of cancers in various studies. Although squamous cell carcinomas are clearly related to alcohol exposure, the risk of adenocarcinoma is much lower, or nil (Lagergren ; Wu ; Lindblad ; Pandeya ). Currently, adenocarcinomas comprise approximately 70% of oesophageal cancers in men in the UK, and 40% in women (see section 8, in Cancers attributable to overweight and obesity). However, the studies currently used to estimate the RR of oesophageal cancer in relation to alcohol do not distinguish between the histological subtypes, and no correction to the estimate for the UK has been made on this basis. We chose to use the estimates of alcohol consumption in the UK based on population survey data (the National Diet and Nutrition Survey). However, it is well known that surveys produce figures far lower than would be expected from alcohol sales. Alcohol sales are estimated based on clearance data produced by HM Revenue and Customs (HMRC). Not all alcohol that is cleared is actually consumed; for example, it is conceivable that some of it may be thrown away when it passes its best-before date. Conversely, not all alcohol that is consumed in the UK is cleared by HMRC; for example, home brew and illegally imported alcohol. Table 6 compares consumption as estimated by the General Household Survey (Goddard, 2006) and from clearance data produced by HM Revenue and Customs (HMRC, 2008). The large difference between the two sets of data is unlikely to be due to large amounts of purchased alcohol not being consumed. Both the General Household Survey and the Government's alcohol strategy (HMG, 2007) believe that many people underestimate the amount of alcohol they drink. However, as estimates of risk are generally based on responses to questionnaires, they are likely to overestimate the risk in relation to actual alcohol consumption. It is more appropriate, therefore, to use estimates of alcohol intake from (self-reported) survey data than the more accurate clearance data.
Table 6

UK alcohol consumption per adult

  General Household Surveya
HM Revenue and Customsb
Year Units per week Litres of pure alcohol per year Units per week Litres of pure alcohol per year
199010.85.319.210
200012.06.220.210.5
200510.85.621.911.4

General Household Survey (Goddard, 2006).

HM Revenue and Customs (HMRC, 2008).

The current estimate (3.6% of new cancers in 2010 related to alcohol) is similar to the figure published by Doll and Peto (2003) – that around 6% of UK cancer deaths could be avoided if people did not drink. The estimation is based on the attribution to alcohol of 2/3 deaths from alcohol-related cancers (mouth, pharynx, larynx, oesophagus) in men and 1/3 in women, plus ‘a small proportion’ of liver cancer deaths. A recent publication, based on the risks of alcohol consumption observed in the EPIC study, estimates a rather higher fraction of cancers attributable to alcohol in the UK – especially in men: 8% of cancer in men and 3% in women (Schütze ). The difference appears to be mainly because of the rather higher level and prevalence of alcohol consumption that were used to estimate attributable fractions (an average intake of 35.2 g per day in men and 17.6 g per day in women, cf. Table 2). These were calculated from data available on the World Health Organisation website, which appear to be derived from clearance data, with levels of consumption equivalent to those in Table 6 (on average, annually 13.4 l of alcohol per capita in 2003–5). As noted above, it would seem more appropriate to use self-reported consumption, even though this is an underestimate of the true situation, as the RR estimates in EPIC (as in other cohort studies) are also based on questionnaire data. See acknowledgements on page Si.
  16 in total

1.  The role of tobacco, snuff and alcohol use in the aetiology of cancer of the oesophagus and gastric cardia.

Authors:  J Lagergren; R Bergström; A Lindgren; O Nyrén
Journal:  Int J Cancer       Date:  2000-02-01       Impact factor: 7.396

2.  Carcinogenicity of alcoholic beverages.

Authors:  Robert Baan; Kurt Straif; Yann Grosse; Béatrice Secretan; Fatiha El Ghissassi; Véronique Bouvard; Andrea Altieri; Vincent Cogliano
Journal:  Lancet Oncol       Date:  2007-04       Impact factor: 41.316

3.  A review of human carcinogens--Part E: tobacco, areca nut, alcohol, coal smoke, and salted fish.

Authors:  Béatrice Secretan; Kurt Straif; Robert Baan; Yann Grosse; Fatiha El Ghissassi; Véronique Bouvard; Lamia Benbrahim-Tallaa; Neela Guha; Crystal Freeman; Laurent Galichet; Vincent Cogliano
Journal:  Lancet Oncol       Date:  2009-11       Impact factor: 41.316

4.  A multiethnic population-based study of smoking, alcohol and body size and risk of adenocarcinomas of the stomach and esophagus (United States).

Authors:  A H Wu; P Wan; L Bernstein
Journal:  Cancer Causes Control       Date:  2001-10       Impact factor: 2.506

5.  Body mass, tobacco and alcohol and risk of esophageal, gastric cardia, and gastric non-cardia adenocarcinoma among men and women in a nested case-control study.

Authors:  Mats Lindblad; Luis A García Rodríguez; Jesper Lagergren
Journal:  Cancer Causes Control       Date:  2005-04       Impact factor: 2.506

6.  Alcohol intake and colorectal cancer risk: a dose-response meta-analysis of published cohort studies.

Authors:  Aurélie Moskal; Teresa Norat; Pietro Ferrari; Elio Riboli
Journal:  Int J Cancer       Date:  2007-02-01       Impact factor: 7.396

7.  Moderate alcohol intake and cancer incidence in women.

Authors:  Naomi E Allen; Valerie Beral; Delphine Casabonne; Sau Wan Kan; Gillian K Reeves; Anna Brown; Jane Green
Journal:  J Natl Cancer Inst       Date:  2009-02-24       Impact factor: 13.506

8.  Alcohol consumption and the risks of adenocarcinoma and squamous cell carcinoma of the esophagus.

Authors:  Nirmala Pandeya; Gail Williams; Adèle C Green; Penelope M Webb; David C Whiteman
Journal:  Gastroenterology       Date:  2008-12-27       Impact factor: 22.682

9.  Alcohol attributable burden of incidence of cancer in eight European countries based on results from prospective cohort study.

Authors:  Madlen Schütze; Heiner Boeing; Tobias Pischon; Jürgen Rehm; Tara Kehoe; Gerrit Gmel; Anja Olsen; Anne M Tjønneland; Christina C Dahm; Kim Overvad; Françoise Clavel-Chapelon; Marie-Christine Boutron-Ruault; Antonia Trichopoulou; Vasiliki Benetou; Dimosthenis Zylis; Rudolf Kaaks; Sabine Rohrmann; Domenico Palli; Franco Berrino; Rosario Tumino; Paolo Vineis; Laudina Rodríguez; Antonio Agudo; María-José Sánchez; Miren Dorronsoro; Maria-Dolores Chirlaque; Aurelio Barricarte; Petra H Peeters; Carla H van Gils; Kay-Tee Khaw; Nick Wareham; Naomi E Allen; Timothy J Key; Paolo Boffetta; Nadia Slimani; Mazda Jenab; Dora Romaguera; Petra A Wark; Elio Riboli; Manuela M Bergmann
Journal:  BMJ       Date:  2011-04-07

10.  Lifetime and baseline alcohol intake and risk of colon and rectal cancers in the European prospective investigation into cancer and nutrition (EPIC).

Authors:  Pietro Ferrari; Mazda Jenab; Teresa Norat; Aurelie Moskal; Nadia Slimani; Anja Olsen; Anne Tjønneland; Kim Overvad; Majken K Jensen; Marie-Christine Boutron-Ruault; Françoise Clavel-Chapelon; Sophie Morois; Sabine Rohrmann; Jakob Linseisen; Heiner Boeing; Manuela Bergmann; Dimitra Kontopoulou; Antonia Trichopoulou; Christina Kassapa; Giovanna Masala; Vittorio Krogh; Paolo Vineis; Salvatore Panico; Rosario Tumino; Carla H van Gils; Petra Peeters; H Bas Bueno-de-Mesquita; Marga C Ocké; Guri Skeie; Eiliv Lund; Antonio Agudo; Eva Ardanaz; Dolores C López; Maria-Jose Sanchez; José R Quirós; Pilar Amiano; Göran Berglund; Jonas Manjer; Richard Palmqvist; Bethany Van Guelpen; Naomi Allen; Tim Key; Sheila Bingham; Mathieu Mazuir; Paolo Boffetta; Rudolf Kaaks; Elio Riboli
Journal:  Int J Cancer       Date:  2007-11-01       Impact factor: 7.396

View more
  22 in total

1.  Alcohol and tobacco misuse: Reducing aerodigestive cancer risk.

Authors:  Gavin Wright; Marsha Y Morgan
Journal:  World J Hepatol       Date:  2013-08-27

2.  Cancer incidence attributable to alcohol consumption in Alberta in 2012.

Authors:  Anne Grundy; Abbey E Poirier; Farah Khandwala; Alison McFadden; Christine M Friedenreich; Darren R Brenner
Journal:  CMAJ Open       Date:  2016-09-21

3.  A methodologic framework to evaluate the number of cancers attributable to lifestyle and environment in Alberta.

Authors:  Anne Grundy; Christine M Friedenreich; Abbey E Poirier; Farah Khandwala; Darren R Brenner
Journal:  CMAJ Open       Date:  2016-09-15

4.  Alcohol control efforts in comprehensive cancer control plans and alcohol use among adults in the USA.

Authors:  S Jane Henley; Dafna Kanny; Katherine B Roland; Melissa Grossman; Brandy Peaker; Yong Liu; Susan M Gapstur; Mary C White; Marcus Plescia
Journal:  Alcohol Alcohol       Date:  2014-10-13       Impact factor: 2.826

Review 5.  Poor awareness of risk factors for cancer in Irish adults: results of a large survey and review of the literature.

Authors:  Aoife M Ryan; Samantha Cushen; Harriët Schellekens; Eadaoin Ni Bhuachalla; Lisa Burns; Ursula Kenny; Derek G Power
Journal:  Oncologist       Date:  2015-03-06

6.  Cancer incidence attributable to lifestyle and environmental factors in Alberta in 2012: summary of results.

Authors:  Anne Grundy; Abbey E Poirier; Farah Khandwala; Xin Grevers; Christine M Friedenreich; Darren R Brenner
Journal:  CMAJ Open       Date:  2017-07-07

7.  Annual Total Binge Drinks Consumed by U.S. Adults, 2015.

Authors:  Dafna Kanny; Timothy S Naimi; Yong Liu; Hua Lu; Robert D Brewer
Journal:  Am J Prev Med       Date:  2018-04       Impact factor: 5.043

8.  Development and Validation of Lifestyle-Based Models to Predict Incidence of the Most Common Potentially Preventable Cancers.

Authors:  Juliet A Usher-Smith; Stephen J Sharp; Robert Luben; Simon J Griffin
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2018-09-13       Impact factor: 4.254

9.  The proportion of postmenopausal breast cancer cases in the Netherlands attributable to lifestyle-related risk factors.

Authors:  W A van Gemert; C I Lanting; R A Goldbohm; P A van den Brandt; H G Grooters; E Kampman; L A L M Kiemeney; F E van Leeuwen; E M Monninkhof; E de Vries; P H Peeters; S G Elias
Journal:  Breast Cancer Res Treat       Date:  2015-06-05       Impact factor: 4.872

Review 10.  Ethanol versus Phytochemicals in Wine: Oral Cancer Risk in a Light Drinking Perspective.

Authors:  Elena M Varoni; Giovanni Lodi; Marcello Iriti
Journal:  Int J Mol Sci       Date:  2015-07-27       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.